![David Kuhns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Kuhns
Hoofd Techniek/Wetenschap/O&O bij Prosomnus Sleep Technologies, Inc.
Profiel
David Kuhns has worked as the Chief Science Officer at Prosomnus Sleep Technologies, Inc. since 2016.
Actieve functies van David Kuhns
Bedrijven | Functie | Begin |
---|---|---|
Prosomnus Sleep Technologies, Inc.
![]() Prosomnus Sleep Technologies, Inc. Medical SpecialtiesHealth Technology Prosomnus Sleep Technologies, Inc. engages in development of a sleep device to control snore. It features the MicrO2 obstructive sleep apnea and snore device, this strategic move enables ProSomnus to treat the rapidly growing number of patients with obstructive sleep apnea (OSA). The company was founded by Len Liptak, Dave Kuhns and Sung Kim on March 1, 2017 and is headquartered in Pleasanton, CA. | Hoofd Techniek/Wetenschap/O&O | 01-10-2016 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Prosomnus Sleep Technologies, Inc.
![]() Prosomnus Sleep Technologies, Inc. Medical SpecialtiesHealth Technology Prosomnus Sleep Technologies, Inc. engages in development of a sleep device to control snore. It features the MicrO2 obstructive sleep apnea and snore device, this strategic move enables ProSomnus to treat the rapidly growing number of patients with obstructive sleep apnea (OSA). The company was founded by Len Liptak, Dave Kuhns and Sung Kim on March 1, 2017 and is headquartered in Pleasanton, CA. | Health Technology |